Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-30

Clinical Trial Update: Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding flecainide to metoprolol more effectively suppresses ventricular arrhythmias in arrhythmic mitral valve prolapse vs meto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL (METOPROLOL TARTRATE)
  • flecainide (flecainide)

Snippet

Sponsor: Oslo University Hospital | Conditions: Mitral Valve Prolapse, Ventricular Arrhythmias and Cardiac Arrest | Phase 3 | Status: RECRUITING